Novel liposomes composed of dimyristoylphosphatidylcholine and trehalose surfactants inhibit the growth of tumor cells along with apoptosis

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 8, 2013, Pages 1258-1262

  Matsumoto, Yoko ^a   Cao, E ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Antitumor effect; Apoptosis; Trehalose surfactant

Indexed keywords

CASPASE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOME; PROTEIN BAX; TREHALOSE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL ACTIVATION; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; MALE; MEMBRANE FLUIDITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; STOMACH CARCINOMA; VISCOSITY; ZETA POTENTIAL;

EID: 84883157796     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00266     Document Type: Article

References (21)

1. Gabius HJ, Engelhardt R, Hellmann T, Midoux P, Monsigny M, Nagel GA, Vehmeyer K. Characterization of membrane lectins in human colon carcinoma cells by flow cytofluorometry, drug targeting and affinity chromatography. Anticancer Res., 7, 109-112 (1987).
2. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology, 3, 97-130 (1993).
3. Uedaira H, Okouchi S, Tsuda S, Uedaira H. Hydration of glucose and galactose derivatives. Bull. Chem. Soc. Jpn., 74, 1857-1861 (2001).
4. Yamazaki N, Jigami Y, Gabius HJ, Kojima S. Preparation and characterization of neoglycoprotein-liposome conjugates: A promising approach to developing drug delivery materials applying sugar chain ligands. Trends Glycosci. Glycotechnol., 13, 319-329 (2001).
5. Ueoka R, Matsumoto Y, Moss RA, Swarup S, Sugii A, Harada K, Kikuchi J, Murakami Y. Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity. J. Am. Chem. Soc., 110, 1588-1595 (1988).
6. Matsumoto Y, Kato T, Iseki S, Suzuki H, Nakano K, Iwahara M, Ueoka R. Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells. Bioorg. Med. Chem. Lett., 9, 1937-1940 (1999).
7. Matsumoto Y, Iwamoto Y, Matsushita T, Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int. J. Cancer, 115, 377-382 (2005).
8. Iwamoto Y, Matsumoto Y, Ueoka R. Induction of apoptosis of human lung carcinoma cells by hybrid liposomes containing polyoxyethylenedodecyl ether. Int. J. Pharm., 292, 231-239 (2005).
9. Shimoda S, Ichihara H, Matsumoto Y, Ueoka R. Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo. Int. J. Pharm., 372, 162-168 (2009).
10. Ichihara H, Ueno J, Umebayashi M, Matsumoto Y, Ueoka R. Chemotherapy with hybrid liposomes for acute lymphatic leukemia leading to apoptosis in vivo. Int. J. Pharm., 406, 173-178 (2011).
11. Komizu Y, Matsumoto Y, Ueoka R. Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis. Bioorg. Med. Chem. Lett., 16, 6131-6134 (2006).
12. Komizu Y, Nakata S, Goto K, Matsumoto Y, Ueoka R. Membrane-targeted nanotherapy with hybrid liposomes for tumor cells leading to apoptosis. ACS Med. Chem., 2, 275-279 (2011).
13. Ichihara H, Nagami H, Kiyokawa T, Matsumoto Y, Ueoka R. Chemotherapy using hybrid liposomes along with induction of apoptosis. Anticancer Res., 28, 1187-1195 (2008).
14. Matsumoto Y, Kato T, Suzuki H, Hirose S, Naiki Y, Hirashima M, Ueoka R. Highly specific inhibitory effect of three-component hybrid liposomes including sugar surfactants on the growth of glioma cells. Bioorg. Med. Chem. Lett., 10, 2617-2619 (2000).
15. Shimada K, Miyagishima A, Sadzuka Y, Nozawa Y, Mochizuki Y, Ohshima H, Hirota S. Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes. J. Drug Target., 3, 283-289 (1995).
16. Ishiyama M, Shiga M, Sasamoto K, Mizoguchi M, He P-. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem. Pharm. Bull., 41, 1118-1122 (1993).
17. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin., 61, 69-90 (2011).
18. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J. Surg. Oncol., 107, 230-236 (2013).
19. Damadian R, Zaner K, Hor D, Dimaio T. Human tumors by NMR. Physiol. Chem. Phys., 5, 381-402 (1973).
20. Inbar M. Fluidity of membrane lipids: a single cell analysis of mouse normal lymphocytes and malignant lymphoma cells. FEBS Lett., 67, 180-185 (1976).
21. Shinitzky M. Membrane fluidity in malignancy. Adversative and recuperative. Biochim. Biophys. Acta, 738, 251-261 (1984).